Becton Dickinson Q3 FY25: where the revenue came from and where it went
The whole income statement of Becton Dickinson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Aug 7, 2025
Revenue$5.51B
+10% year over year
Gross profit$2.63B
48% margin
Operating profit$0.88B
16% margin
Net profit$0.57B
10% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 5.51 | 100% | +10% |
| Medical | 2.93 | 53% | |
| Interventional | 1.33 | 24% | |
| Life sciences | 1.25 | 23% | |
| Cost of revenue | −2.88 | 52% | |
| Gross profit | 2.63 | 48% margin | +2pp |
| R&D | −0.30 | 5% | −1pp |
| SG&A | −1.32 | 24% | +0pp |
| Other | −0.14 | 3% | +0pp |
| Operating profit | 0.88 | 16% margin | +4pp |
| Interest & other costs | −0.18 | ||
| Tax | −0.13 | ||
| Net profit | 0.57 | 10% margin | +1pp |
76 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest